# Effects Of Detrol LA On Memory And Cognition In Elderly Population

> **NCT00411437** · PHASE4 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 220 (—)

## Conditions studied

- Memory
- Cognition

## Interventions

- **DRUG:** Tolterodine ER
- **DRUG:** Oxybutynin ER

## Key facts

- **NCT ID:** NCT00411437
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 220 (—)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411437, "Effects Of Detrol LA On Memory And Cognition In Elderly Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00411437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*